Bui H N, Sluss P M, Hayes F J, Blincko S, Knol D L, Blankenstein M A, Heijboer A C
Dept. of Clinical Chemistry, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Clinical Pathology Core Laboratory, Massachusetts General Hospital, Boston, MA, USA.
Clin Chim Acta. 2015 Oct 23;450:227-32. doi: 10.1016/j.cca.2015.08.019. Epub 2015 Aug 29.
The objective of our study was to determine reference intervals and biologic variation for testosterone (T), free testosterone (fT), and free androgen index (FAI) in women with accurate methods and to test the discriminative value of these parameters in a polycystic ovary syndrome (PCOS)-population.
Serum was obtained daily during a normal menstrual cycle from 25 healthy women (677 data-points). A single serum sample was obtained from 44 PCOS-patients. T was measured by LC–MS/MS and by Architect® 2nd generation T Immunoassay. Sex hormone-binding globulin was measured to calculate fT and FAI. Results: Reference intervals which were established in healthy women with an ovulatory menstrual cycle were T = 0.3-1.6 nmol/L and 0.5-2.0 nmol/L, fT = 5.2-26 pmol/L and 7.2-33 pmol/L, and FAI = 0.4-2.9 and 0.6-4.4, by LC-MS/MS and immunoassay, respectively. T, fT and FAI were higher in PCOS patients than in controls (p b 0.0001). The areas under the curve of receiver operator characteristic (ROC) plots were not different for T, fT, or FAI when T was measured by LC–MS/MS versus immunoassay based on prediction of PCOS. FAI and fT were the strongest predictors of PCOS.
When based upon the appropriate reference intervals and ROC analysis, LC-MS/MS and second generation immunoassay have equivalent clinical utility for the diagnosis of PCOS.
我们研究的目的是采用准确的方法确定女性睾酮(T)、游离睾酮(fT)和游离雄激素指数(FAI)的参考区间及生物学变异,并在多囊卵巢综合征(PCOS)人群中检验这些参数的判别价值。
在正常月经周期中,每天从25名健康女性获取血清(共677个数据点)。从44名PCOS患者获取单个血清样本。采用液相色谱-串联质谱法(LC–MS/MS)和Architect®第二代T免疫测定法测定T。测定性激素结合球蛋白以计算fT和FAI。结果:在有排卵月经周期的健康女性中建立的参考区间,通过LC-MS/MS法分别为T = 0.3 - 1.6 nmol/L和0.5 - 2.0 nmol/L,fT = 5.2 - 26 pmol/L和7.2 - 33 pmol/L,FAI = 0.4 - 2.9和0.6 - 4.4;通过免疫测定法分别为T = 0.5 - 2.0 nmol/L,fT = 7.2 - 33 pmol/L,FAI = 0.6 - 4.4。PCOS患者的T、fT和FAI高于对照组(p < 0.0001)。基于PCOS预测,当采用LC–MS/MS法与免疫测定法测量T时,T、fT或FAI的受试者操作特征(ROC)曲线下面积无差异。FAI和fT是PCOS最强的预测指标。
基于适当的参考区间和ROC分析,LC-MS/MS法和第二代免疫测定法在PCOS诊断中具有同等临床效用。